Cargando…
Antilung cancer effect of ergosterol and cisplatin-loaded liposomes modified with cyclic arginine-glycine-aspartic acid and octa-arginine peptides
BACKGROUND: Lung cancer is one of the most important diseases threatening human health, and targeted therapy has become the main research direction. This work, therefore, aimed to develop cyclic arginine-glycine-aspartic (RGD) and octa-arginine (R8) peptide-modified ergosterol (ERG)-combined cisplat...
Autores principales: | Wu, Meijia, Huang, Ting, Wang, Juan, Chen, Ping, Mi, Wanwan, Ying, Yuanyuan, Wang, Hangli, Zhao, Dandan, Huang, Shengwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113040/ https://www.ncbi.nlm.nih.gov/pubmed/30113492 http://dx.doi.org/10.1097/MD.0000000000011916 |
Ejemplares similares
-
Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion
por: Matsuo, Shingo, et al.
Publicado: (2013) -
A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy
por: QIN, LI, et al.
Publicado: (2014) -
Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation
por: Wang, Chen, et al.
Publicado: (2022) -
Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
por: Jiang, Kanqiu, et al.
Publicado: (2018) -
Physical stability of arginine-glycine-aspartic acid peptide coated on anodized implants after installation
por: Huh, Jung-Bo, et al.
Publicado: (2013)